CareLit · DOI-Nachweis · Klinische Neurophysiologie
Early Intervention in Parkinson's Disease with Cabergoline – Results of an Open-Label Long-Term Trial with Focus on Sleep Disturbances
DOI 10.1055/s-2006-939191
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Jost, M Ueberall
ZeitschriftKlinische Neurophysiologie
Ausgabe03/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Cabergoline (CBG), a long-acting ergoline derivative, is frequently used for the add-on treatment of Parkinson's disease (PD). Study Objectives: To assess the safety and efficacy of CBG for the first-line treatment of PD with special regard to disease-/treatment-related sleep disturbances. Design: open-label, long-term (52 weeks), multicentre observational trial. Setting: 245 patients (44.9% female) with an ag…
Zitieren
Zitierempfehlung
W Jost, M Ueberall (2006) Early Intervention in Parkinson's Disease with Cabergoline – Results of an Open-Label Long-Term Trial with Focus on Sleep Disturbances. Klinische Neurophysiologie (03). https://doi.org/10.1055/s-2006-939191
Mit CareLit weiterarbeiten